Skip to main content
Qurient Co., Ltd. logo

Qurient Co., Ltd. — Investor Relations & Filings

Ticker · 115180 ISIN · KR7115180002 KO Professional, scientific and technical activities
Open in API
Filings indexed 437 across all filing types
Latest filing 2026-05-21 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 115180

About Qurient Co., Ltd.

http://www.qurient.com/

Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권행사
Share Issue/Capital Change Classification · 85% confidence The document is a regulatory filing disclosing the exercise of employee stock options and the resulting issuance of new shares, including corrected details (new share listing date, number of shares, exercise breakdown, etc.). This constitutes a corporate action of share issuance/capital change. It is not an annual or interim report, nor a dividend, M&A or director dealing. Therefore, it fits the Share Issue/Capital Change category (SHA).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is labeled “분기보고서” covering the period 2026.01.01–2026.03.31 (the first quarter), contains detailed company overview, changes in subsidiaries, share capital tables, financial statement schedules, and appears to be the full quarterly regulatory filing rather than a mere announcement. This corresponds to an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about the securities owned by an executive or major shareholder, including changes in ownership, types of securities, and dates of transactions. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal ownership disclosure. This matches the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels. The document length is 2533 characters, which is consistent with a detailed ownership report rather than a brief announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about the ownership of securities by an executive named Yu Chang Eyun, including share counts, ownership percentages, and changes in holdings. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal disclosure of insider holdings. This matches the definition of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels. The document length is 2534 characters, which is consistent with a detailed ownership report rather than a brief announcement or certification. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-04-30 Korean
주식매수선택권행사
Transaction in Own Shares Classification · 95% confidence The document is a detailed report on stock options exercise, including the number of shares exercised, exercise prices, dates, and remaining stock options. It provides comprehensive data on stock option grants and exercises, including specific dates and quantities. This type of document is a report on transactions involving the company's own shares, specifically stock option exercises leading to new share issuance. It is not an announcement of a report, nor a general regulatory filing or a management change. It fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or issuance of shares, including stock option exercises.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about the ownership of securities by an individual named Heo Tae Suk, including the number of shares owned, changes in ownership, and related dates. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal notification of insider holdings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives. The document length is 2503 characters, and it contains substantive data about share ownership changes, not just an announcement or certification. Therefore, the appropriate classification is DIRS (Director's Dealing).
2026-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.